Explainer · August 8, 2026 · 5 min · By Fletcher Imafidon
Slow Mohs, Explained: Why Some Skin Cancers Get Their Margins Checked Overnight Instead of in an Hour
Staged excision with permanent paraffin sections trades same-day answers for sharper detection of subtle melanocytic disease. Here is how the technique works, when surgeons reach for it, and what the evidence says about trade-offs.
Most people who read about Mohs micrographic surgery learn one headline fact: the tissue is processed and examined while the patient waits, so the surgeon knows within an hour or two whether the margins are clear. That is true for the frozen section technique used for the vast majority of basal cell and squamous cell carcinomas. But there is a second, slower version of margin-controlled surgery that many patients have never heard of until a dermatologist recommends it. Clinicians call it slow Mohs, or more formally, staged excision with permanent section margin control.
The core logic is identical to standard Mohs. The surgeon removes the visible tumor plus a narrow rim of tissue, maps and inks the specimen, and examines essentially the entire peripheral and deep margin using en face sectioning, the horizontal orientation that lets a pathologist see the full edge of the specimen rather than representative slices. The difference is the processing. Instead of freezing the tissue and cutting it on a cryostat within minutes, the lab fixes the tissue in formalin, embeds it in paraffin overnight, and often applies immunohistochemical stains before a dermatopathologist reads the slides. The patient goes home with a bandaged open wound, or a temporary dressing over the surgical site, and returns a day or more later. If the margin is positive, another stage is taken from the mapped location. Only when the margins read clear is the wound reconstructed.
Why accept the wait? The answer is cellular. Frozen sections introduce freezing artifact, small distortions in cell architecture that matter little when the target is a nest of basaloid carcinoma cells but matter enormously when the target is a single atypical melanocyte. This is the central problem with lentigo maligna, the slow-growing melanoma in situ subtype that favors chronically sun-damaged skin on the face and scalp. Sun-damaged skin already contains a higher baseline density of melanocytes, and the diagnostic question at the margin is whether the melanocytes present are part of the tumor or part of the background. On frozen tissue, keratinocytes can vacuolize and mimic melanocytes, and true melanocytes can be hard to count. Paraffin sections preserve architecture, and stains such as MART-1 and SOX10 label melanocytes specifically, letting the pathologist compare melanocyte density and pattern at the margin against normal control skin.
The clinical payoff shows up in recurrence data. Lentigo maligna is notorious for subclinical extension, meaning tumor cells that spread well beyond the visible pigmented patch. Standard wide local excision with a fixed 5 millimeter margin, the historical default for melanoma in situ, has reported recurrence rates in the range of roughly 8 to 20 percent for lentigo maligna on the head and neck, largely because the fixed margin misses those invisible extensions. Published series of staged excision with comprehensive permanent section margin control report recurrence rates closer to 1 to 2 percent. The mechanism is not mysterious: the technique keeps cutting until the actual biological edge of the tumor is confirmed clear, rather than guessing at it.
Slow Mohs comes in several named variants. The square technique removes a thin picture-frame strip of tissue around the lesion for margin analysis while leaving the central tumor in place until margins clear. The spaghetti technique works similarly with a narrow ribbon of peripheral tissue. Some academic centers have also developed rapid MART-1 immunostaining protocols for frozen sections, which can bring melanocytic margin assessment back into a same-day workflow. This works well in experienced hands, but it requires specialized lab capability and a Mohs surgeon comfortable reading immunostained frozen melanocytic margins, which is why it is not universally offered.
The trade-offs are real and worth naming plainly. Patients live with an open or temporarily dressed wound between stages, sometimes for several days. The process may involve two, three, or more visits. Reconstruction is delayed. For anxious patients, the waiting period between stages is often the hardest part. On the other hand, delayed reconstruction has a quiet advantage: the surgeon designs the repair only after the final defect size is known, avoiding a flap or graft that would have to be revised if a margin came back positive.
A few practical points for anyone facing this recommendation. Ask how the interval wound will be dressed and what care it needs at home. Ask who reads the permanent sections, since dermatopathology review with immunostains is a core part of the technique's accuracy. And ask about expected number of stages, because lentigo maligna on the face frequently requires margins beyond 5 millimeters, and knowing that up front prevents surprise.
Bottom line: slow Mohs is not a lesser or outdated version of Mohs surgery. It is the same margin-mapping logic applied through a processing method better suited to melanocytic tumors, trading speed for the tissue clarity those tumors demand. For lentigo maligna in cosmetically sensitive locations, that trade has some of the strongest recurrence data in cutaneous oncology behind it.
Related reading: Advances in skin cancer detection and Mohs.
Further reading: Review on the Role of Paraffin-embedded Margin-controlled Mohs Micrographic Surgery to Treat Skin Tumors (Actas Dermosifiliogr 2024); Mohs Micrographic Surgery: A Narrative Review of Current Practices, Emerging Trends, and Case-Based Insights (Adv Ther 2025); Local Recurrence Rates of Extramammary Paget Disease Are Lower After Mohs Micrographic Surgery Compared With Wide Local Excision: A Systematic Review and Meta-Analysis (Dermatol Surg 2023).